GT Biopharma Inc. (NASDAQ:GTBP) saw its stock rise 4.1% on Wednesday after announcing that its Phase 1 study for its lead immunotherapy, GTB 3650, has progressed to a higher dose tier. GTB 3650 — a ...

The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...

French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). The company’s tetraspecific antibody controlled tumors and improved survival in mice and ...

Think of it as an internal detox and reset, clearing the bloodstream so your immune system and organs can function at full ...

Yale researchers have uncovered a way to make a type of white blood cells known as natural killer cells — which kill infected, damaged, or malignant cells in the body — more effective against cancer.

Natural killer (NK) cells represent an important class of immune cells involved in anti-tumor immunity. Once identifying a tumor cell, NK cells use small particles to kill the cancer cell. Our ...

As the immune system ages, it reacts more slowly to pathogens, vaccines become less effective, and the risk of cancer ...